These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 1971105)
1. Interactions of 7-[3-(4-[2,3-dimethylphenyl]piperazinyl)-propoxy]-2(1H)-quinolinone binding in rat striatum: effects of lesions. Zhang X; Nakata Y; Kikuchi T; Segawa T Pharm Res; 1990 Mar; 7(3):280-2. PubMed ID: 1971105 [TBL] [Abstract][Full Text] [Related]
2. 7-[3-(4-[2,3-Dimethylphenyl]piperazinyl)propoxy]-2(1H)-quinolinone (OPC-4392), a presynaptic dopamine autoreceptor agonist and postsynaptic D2 receptor antagonist. Yasuda Y; Kikuchi T; Suzuki S; Tsutsui M; Yamada K; Hiyama T Life Sci; 1988; 42(20):1941-54. PubMed ID: 3130534 [TBL] [Abstract][Full Text] [Related]
3. 7-(4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butyloxy)-3,4-dihydro-2(1H)-quinolinone (OPC-14597), a new putative antipsychotic drug with both presynaptic dopamine autoreceptor agonistic activity and postsynaptic D2 receptor antagonistic activity. Kikuchi T; Tottori K; Uwahodo Y; Hirose T; Miwa T; Oshiro Y; Morita S J Pharmacol Exp Ther; 1995 Jul; 274(1):329-36. PubMed ID: 7616416 [TBL] [Abstract][Full Text] [Related]
4. Selective blockade of dopamine D-1 receptor by SCH 23390 affects dopamine agonist binding to 3H-spiperone labeled D-2 receptors in rat striatum. Zhang X; Segawa T Jpn J Pharmacol; 1989 Jul; 50(3):333-45. PubMed ID: 2569545 [TBL] [Abstract][Full Text] [Related]
5. Differential anatomical location of [3H]-N,n-propylnorapomorphine and [3H]-spiperone binding sites in the striatum and substantia nigra of the rat. Hall MD; Jenner P; Kelly E; Marsden CD Br J Pharmacol; 1983 Jun; 79(2):599-610. PubMed ID: 6418246 [TBL] [Abstract][Full Text] [Related]
6. D-2 receptor-mediated inhibition by a substituted quinolinone derivative, 7-[3-(4-(2,3-dimethylphenyl)piperazinyl)propoxy]-2(1H)-quinolinone (OPC-4392), of dopaminergic neurons in the ventral tegmental area. Momiyama T; Sasa M; Takaori S Life Sci; 1990; 47(9):761-9. PubMed ID: 1977066 [TBL] [Abstract][Full Text] [Related]
7. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding. Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767 [TBL] [Abstract][Full Text] [Related]
8. Selective and stereospecific interactions of R-SK & F 38393 with [3H]piflutixol but not [3H]spiperone binding to striatal D1 and D2 dopamine receptors: comparisons with SCH 23390. O'Boyle KM; Waddington JL Eur J Pharmacol; 1984 Mar; 98(3-4):433-6. PubMed ID: 6144559 [TBL] [Abstract][Full Text] [Related]
9. Binding characteristics of the dopamine agonist/antagonist [3H]terguride (transdihydrolisuride) in the rat striatum. Valchár M; Vrsecká M; Krejcí I; Dlabac A Eur J Pharmacol; 1987 Apr; 136(1):97-101. PubMed ID: 3297739 [TBL] [Abstract][Full Text] [Related]
10. Effect of 7-(3-[4-(2,3-dimethylphenyl)piperazinyl]propoxy)- 2(1H)-quinolinone (OPC-4392), a newly synthesized agonist for presynaptic dopamine D2 receptor, on tyrosine hydroxylation in rat striatal slices. Kiuchi K; Hirata Y; Minami M; Nagatsu T Life Sci; 1988; 42(3):343-9. PubMed ID: 2892110 [TBL] [Abstract][Full Text] [Related]
11. GTP regulation of (-)-stepholidine binding to R(H) of D1 dopamine receptors in calf striatum. Dong ZJ; Chen LJ; Jin GZ; Creese I Biochem Pharmacol; 1997 Jul; 54(2):227-32. PubMed ID: 9271326 [TBL] [Abstract][Full Text] [Related]
12. Characterization of the binding of 3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatum. Billard W; Ruperto V; Crosby G; Iorio LC; Barnett A Life Sci; 1984 Oct; 35(18):1885-93. PubMed ID: 6387355 [TBL] [Abstract][Full Text] [Related]
13. Effects of chronic antidepressant treatment on dopamine-related [3H]SCH 23390 and [3H]spiperone binding in the rat striatum. Paetsch PR; Greenshaw AJ Cell Mol Neurobiol; 1992 Dec; 12(6):597-606. PubMed ID: 1490276 [TBL] [Abstract][Full Text] [Related]
14. Characterization of binding of 3H-SCH 23390 to dopamine D-1 receptors. Correlation to other D-1 and D-2 measures and effect of selective lesions. Hyttel J; Arnt J J Neural Transm; 1987; 68(3-4):171-89. PubMed ID: 2881976 [TBL] [Abstract][Full Text] [Related]
15. Chronic treatment with antidepressants decreases the number of [3H]SCH 23390 binding sites in the rat striatum and limbic system. Klimek V; Nielsen M Eur J Pharmacol; 1987 Jul; 139(2):163-9. PubMed ID: 3308491 [TBL] [Abstract][Full Text] [Related]
16. Binding of 3H-spiperone and 3H-(-)-sulpiride to dopamine D2 receptors in rat striatal membranes: methodological considerations and demonstration of the identical nature of the binding sites for the two ligands. Urwyler S; Coward D Naunyn Schmiedebergs Arch Pharmacol; 1987 Feb; 335(2):115-22. PubMed ID: 2951601 [TBL] [Abstract][Full Text] [Related]
17. Kainic acid lesions of striatum and decortication reduce specific [3H]sulpiride binding in rats, so D-2 receptors exist post-synaptically on corticostriate afferents and striatal neurons. Theodorou A; Reavill C; Jenner P; Marsden CD J Pharm Pharmacol; 1981 Jul; 33(7):439-44. PubMed ID: 6115030 [TBL] [Abstract][Full Text] [Related]
18. Identification of dopamine "D3" and "D4" binding sites, labelled with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectively. Urwyler S; Markstein R J Neurochem; 1986 Apr; 46(4):1058-67. PubMed ID: 2936868 [TBL] [Abstract][Full Text] [Related]
19. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum. Thomas KL; Rose S; Jenner P; Marsden CD Biochem Pharmacol; 1992 Jul; 44(1):83-91. PubMed ID: 1321631 [TBL] [Abstract][Full Text] [Related]
20. In vivo [3H]spiperone binding: evidence for accumulation in corpus striatum by agonist-mediated receptor internalization. Chugani DC; Ackermann RF; Phelps ME J Cereb Blood Flow Metab; 1988 Jun; 8(3):291-303. PubMed ID: 2966803 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]